Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.

Abstract:

OBJECTIVES:To estimate the prevalence of pulmonary arterial hypertension (PAH) and risk factors for PAH in patients registered in the Chinese SLE Treatment and Research group (CSTAR) database, the first online registry of Chinese patients with systemic lupus erythematosus (SLE). METHODS:A prospective cross-sectional study of patients with SLE was conducted using the CSTAR registry. Resting transthoracic echocardiography was used to estimate pulmonary artery pressure (PAP); PAH was defined as systolic PAP (PASP)≥40 mmHg. Patients with interstitial lung disease, valvular disease or cardiomyopathy were excluded because of disease influence on PAP. We explored potential risk factors for PAH including patient characteristics, organ involvement, laboratory findings and SLE disease activity. RESULTS:Of 1934 patients with SLE, 74 had PASP with 54.2±17.1 (40,106) mmHg and were diagnosed with probable PAH. The incidences of lupus nephritis, pleuritis, pericarditis, hypocomplementemia, anti-SSA, and anti-ribonucleoprotein (RNP) were significantly higher in patients with PAH than in those without (p<0.05). SLE disease activity was significantly higher in patients with PAH than in unaffected patients (p<0.05). Multivariate analysis indicated that pericarditis (odds ratio (OR)=4.248), pleuritis (OR=3.061) and anti-RNP (OR=2.559) were independent risk factors for PAH in patients with SLE (p<0.05). CONCLUSIONS:The possible prevalence of PAH was 3.8% in Chinese patients with SLE in the CSTAR registry. The significant association of pericarditis, pleuritis and anti-RNP positivity with PAH suggests that higher disease activity and vasculopathy may both contribute to the development of PAH in SLE, which need be treated aggressively to improve prognosis.

journal_name

Lupus

journal_title

Lupus

authors

Li M,Wang Q,Zhao J,Li Z,Ye Z,Li C,Li X,Zhu P,Wang Z,Zheng Y,Li X,Zhang M,Tian Z,Liu Y,He J,Zhang F,Zhao Y,Zeng X,CSTAR co-authors.

doi

10.1177/0961203314527366

subject

Has Abstract

pub_date

2014-09-01 00:00:00

pages

1085-91

issue

10

eissn

0961-2033

issn

1477-0962

pii

0961203314527366

journal_volume

23

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • Acute sideroblastic anemia in active systemic lupus erythematosus.

    abstract::This work describes the development of sideroblastic anemia (SA) during the clinical activity of systemic lupus erythematosus (SLE) in two patients. The cases refer to two women with SLE who developed SA during a relapse of the illness. Both patients fulfilled at least four criteria of the American Association of Rheu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300305

    authors: Jiménez-Balderas FJ,Morales-Polanco MR,Gutierrez L

    更新日期:1994-06-01 00:00:00

  • Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a clinically diverse, complex autoimmune disease which may present with coincident onset of many criteria or slow, gradual symptom accrual. Early intervention has been postulated to delay or prevent the development of more serious sequelae. One option for treatment in this setting...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307078579

    authors: James JA,Kim-Howard XR,Bruner BF,Jonsson MK,McClain MT,Arbuckle MR,Walker C,Dennis GJ,Merrill JT,Harley JB

    更新日期:2007-01-01 00:00:00

  • Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

    abstract:OBJECTIVE:The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were co...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312470977

    authors: Iacobaeus E,Hopia L,Khademi M,Lundén M,Hammarin AL,Svenungsson E,Andersson M

    更新日期:2013-03-01 00:00:00

  • Wegener's granulomatosis: disease course, assessment of activity and extent and treatment.

    abstract::Wegener's granulomatosis (WG) belongs to the group of necrotizing primary systemic vasculitides of unknown etiology, that are associated with anti-neutrophil cytoplasmic antibodies. The pathological hallmark of WG is the coexistence of vasculitis and granuloma. Due to more sensitive diagnostic instruments, especially ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920118

    authors: de Groot K,Gross WL

    更新日期:1998-01-01 00:00:00

  • Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

    abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312444172

    authors: De Carolis S,Botta A,Santucci S,Salvi S,Moresi S,Di Pasquo E,Del Sordo G,Martino C

    更新日期:2012-06-01 00:00:00

  • Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density.

    abstract::The purpose of this study was to evaluate the clinical characteristics of women with systemic lupus erythematosus (SLE) sent for a dual energy X-ray absorptiometry (DEXA) study, and to analyse the factors associated with a lower bone mineral density in these patients. Women with SLE who had a DEXA done between 1 Janua...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu1036oa

    authors: Pineau CA,Urowitz MB,Fortin PJ,Ibanez D,Gladman DD

    更新日期:2004-01-01 00:00:00

  • Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.

    abstract::The complexity of the therapeutic approach in systemic lupus erythematosus (SLE) is increased by the large number of patients who do not respond to the first-line therapies and by relapses after initial clinical remission. In these patients, second-line drugs are often prescribed according to individual clinical decis...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309106174

    authors: Ramos-Casals M,Soto MJ,Cuadrado MJ,Khamashta MA

    更新日期:2009-08-01 00:00:00

  • Prevalence and incidence of systemic lupus erythematosus in the adult population of Estonia.

    abstract::Studies have demonstrated considerable variability in systemic lupus erythematosus (SLE) incidence and prevalence estimates. Lack of reliable epidemiological data may hinder evidence-based health care planning. The aim of the present study was to estimate the prevalence and incidence of SLE in the Estonian adult popul...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316686705

    authors: Otsa K,Talli S,Harding P,Parsik E,Esko M,Teepere A,Tammaru M

    更新日期:2017-09-01 00:00:00

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice.

    abstract::The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB x NZWF1 (B/WF1) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease bega...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu483oa

    authors: Hasegawa K,Hayashi T

    更新日期:2003-01-01 00:00:00

  • Primary antiphospholipid antibody syndrome presenting with adrenal insufficiency in a child: case report and review of literature.

    abstract::A 7-year-old boy presented with adrenal insufficiency. He subsequently developed venous thrombosis in the limbs and was diagnosed with primary antiphospholipid syndrome (PAPS) based on clinical and laboratory parameters. Both adrenals were normal on imaging. He required thrombolysis and anticoagulation. The progressiv...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203310397965

    authors: Bhakhri BK,Katewa S,Sharma R,Mahajan S

    更新日期:2011-10-01 00:00:00

  • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

    abstract:OBJECTIVE:To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE). METHODS:A double-blinded, placebo-controlled, randomized clinical trial in 21 patients with severe and active SLE, manifestated primarily by nephritis, serositis or hematological abnormalities. In additi...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/096120399678847588

    authors: van Vollenhoven RF,Park JL,Genovese MC,West JP,McGuire JL

    更新日期:1999-01-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Estrogen receptor alpha gene polymorphism and systemic lupus erythematosus: a possible risk?

    abstract::Estrogens and their receptors may play a role in the pathogenesis of systemic lupus erythematosus. Genetic alterations in the exon 8-coding region of the estrogen receptor alpha alter the intracellular signalling of estrogens, leading in enhanced or diminished activity. We investigated whether genetic alterations in e...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2104oa

    authors: Kassi E,Vlachoyiannopoulos PG,Kominakis A,Kiaris H,Moutsopoulos HM,Moutsatsou P

    更新日期:2005-01-01 00:00:00

  • Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is characterized by the finding of ample serum autoantibodies. The role and the origin of many of these antibodies are still obscure. The aim of this work was to study the occurrence of anti-insulin antibodies (AIA) in SLE, and to postulate, based on AIA determination, on the mechani...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301669081314

    authors: Lidar M,Braf A,Givol N,Langevitz P,Pauzner R,Many A,Livneh A

    更新日期:2001-01-01 00:00:00

  • Association between HLA class II antigens and primary antiphospholipid syndrome from the south of Spain.

    abstract::Recent studies have suggested an association between primary antiphospholipid syndrome (PAPS), antiphospholipid antibodies and some major histocompatibility complex (MHC) antigens. We have studied the relationship between MHC class II antigens and PAPS in 19 patients from the south of Spain. Univariant analysis showed...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400111

    authors: Camps MT,Cuadrado MJ,Ocón P,Alonso A,Gutierrez A,Guil M,Grana MI,de Ramón E

    更新日期:1995-02-01 00:00:00

  • Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.

    abstract:INTRODUCTION:Anti-ganglioside antibodies (AGA) have been associated with several peripheral neuropathies, such as Miller-Fisher syndrome, Guillain-Barré syndrome and multifocal motor neuropathy. They have also been studied in patients with systemic lupus erythematosus (SLE), focusing on neuropsychiatric manifestations ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312436856

    authors: Labrador-Horrillo M,Martinez-Valle F,Gallardo E,Rojas-Garcia R,Ordi-Ros J,Vilardell M

    更新日期:2012-05-01 00:00:00

  • Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.

    abstract::Background While thrombopoeitin (TPO) agonists that act to simulate platelet production have been approved for use in steroid-refractory chronic immune thrombocytopenia purpura (ITP), there are few data on the safety and efficacy of these medications in patients with concurrent systemic lupus erythematosus (SLE) or an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318770023

    authors: Lusa A,Carlson A

    更新日期:2018-09-01 00:00:00

  • Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

    abstract:INTRODUCTION:High-mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316644331

    authors: Jog NR,Blanco I,Lee I,Putterman C,Caricchio R

    更新日期:2016-12-01 00:00:00

  • Decreased diffusion capacity on lung function testing in asymptomatic patients with systemic lupus erythematosus does not predict future lung disease.

    abstract:BACKGROUND:In a previous study performed 9 ± 3.6 years ago, 74 asymptomatic patients with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS) underwent lung function testing. A significantly low diffusion capacity (DLCO) ranging from 45% to 70% was recorded in 28 of the 74 (37.8%) patients who wer...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314566633

    authors: Elalouf O,Fireman E,Levartovsky D,Kaufman I,Rogovski O,Elkayam O,Caspi D,Paran D

    更新日期:2015-08-01 00:00:00

  • Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

    abstract::In examining reasons for premature atherosclerosis in systemic lupus erythematosus (SLE), we previously reported low levels of the cholesterol transport protein apolipoprotein A1 (apoA1) in these patients, and specific antibodies to purified apoA1 were identified in the sera of 5 out of 30 lupus patients. The current ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920262

    authors: Dinu AR,Merrill JT,Shen C,Antonov IV,Myones BL,Lahita RG

    更新日期:1998-01-01 00:00:00

  • 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.

    abstract::Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners, with several controversial points that have not been answered so far. This Obstetric APS Task Force met on the 16th International Congress on Antiphospholipid Antibodies in Manchester, England, to discuss about treatment, diagnos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320954520

    authors: de Jesús GR,Benson AE,Chighizola CB,Sciascia S,Branch DW

    更新日期:2020-10-01 00:00:00

  • Affinity purified human antiphospholipid antibodies bind normal term placenta.

    abstract::Antiphospholipid antibodies (aPL) are associated with an increased incidence of fetal loss, but the pathophysiology remains unclear. One mechanism may involve the binding of aPL directly to the placenta where they may initiate placental thrombosis and infarction. We have developed an immunofluorescent technique to det...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840756

    authors: Donohoe S,Kingdom JC,Mackie IJ

    更新日期:1999-01-01 00:00:00

  • Allergic disorders in systemic lupus erythematosus.

    abstract::Allergic disorders commonly occur in patients with systemic lupus erythematosus (SLE) and allergies to some drugs may occasionally be related to disease flares. We evaluated the prevalence of several types of allergy in 132 patients with SLE and their families and compared the SLE patients with a control group of 66 p...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200311

    authors: Sequeira JF,Cesic D,Keser G,Bukelica M,Karanagnostis S,Khamashta MA,Hughes GR

    更新日期:1993-06-01 00:00:00

  • Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome.

    abstract::Autoantibodies against prothrombin, including lupus anticoagulant antibodies (LAC), have been identified in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). To identify the epitopes of LAC in patients with SLE and APS, we analyzed B cell epitopes of anti-prothrombin Abs. Prothrombi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840963

    authors: Akimoto T,Akama T,Kono I,Sumida T

    更新日期:1999-01-01 00:00:00

  • Systemic lupus erythematosus in the far north of Queensland.

    abstract::An assessment of prevalence for systemic lupus erythematosus (SLE) has been attempted for the population of far north Queensland in Australia. This huge area has a majority Caucasian population living in a tropical environment. Roughly 10% of the population comprises people of Australian Aboriginal or Torres Strait Is...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu381xx

    authors: Bossingham D

    更新日期:2003-01-01 00:00:00

  • Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.

    abstract:OBJECTIVE:The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE). METHODS:We conducted a post-hoc analysis of a long-term followed cohort of Mexican SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600539

    authors: Castillo-Martínez D,Marroquín-Fabián E,Lozada-Navarro AC,Mora-Ramírez M,Juárez M,Sánchez-Muñoz F,Vargas-Barrón J,Sandoval J,Amezcua-Guerra LM

    更新日期:2016-01-01 00:00:00

  • Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.

    abstract::We have explored the relationship between possible hemostatic changes and clinical manifestation of the systemic lupus erythematosus (SLE) as a function of greater or lesser disease activity according to Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) criteria. Endothelial injury and hypercoagulab...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319899478

    authors: Cicarini WB,Duarte RCF,Ferreira KS,Loures CMG,Consoli RV,Neiva CLS,de Pádua PM,Nunes FFC,Alves LCV,Reis EA,Moreira CC,Guimarães TMPD,de Toledo VPCP,Carvalho MDG

    更新日期:2020-02-01 00:00:00

  • The blood-brain barrier in systemic lupus erythematosus.

    abstract::Central nervous system (CNS) involvement may occur in 20-70% of systemic lupus erythematosus (SLE) patients where neurological symptoms are overt; this is termed neuropsychiatric lupus or NPSLE. This review summarizes evidence that damage to the brain endothelium forming the blood-brain barrier (BBB) is a contributory...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu501oa

    authors: Abbott NJ,Mendonça LL,Dolman DE

    更新日期:2003-01-01 00:00:00

  • Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies. Recently, a specific highly activated T helper cell subset, follicular helper T (Tfh) cell, has emerged as a key immunoregulator of germinal center (GC) formation and high-affinity antibody productio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314567750

    authors: Zhang X,Lindwall E,Gauthier C,Lyman J,Spencer N,Alarakhia A,Fraser A,Ing S,Chen M,Webb-Detiege T,Zakem J,Davis W,Choi YS,Quinet R

    更新日期:2015-08-01 00:00:00